EDAP TMS S.A.
Nasdaq FOCL · 69120 Vaulx En Velin, France
Works in Oncology · Renal & urogenital · Women's health
EDAP TMS S.A. is a clinical trial sponsor based in 69120 Vaulx En Velin, France, listed as Nasdaq FOCL. It has 4 active clinical trials with 3,300 planned participants, in Oncology, Renal & urogenital and Women's health. Since 2021 it has completed 2 trials and stopped 1 early.
Trial track record · since 2021
Financials · Nasdaq FOCL
Pipeline · 4 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about EDAP TMS S.A
EDAP TMS S.A is lead sponsor of 4 active clinical trials on ClinicalTrials.gov, with 3,300 planned participants, in Oncology, Renal & urogenital, Women's health. Since 2021 it has completed 2 trials and stopped 1 early.
EDAP TMS S.A is based in 69120 Vaulx En Velin, France and is listed as Nasdaq FOCL. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with EDAP TMS S.A; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-06-12.
Approve Suite is not affiliated with EDAP TMS S.A..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.